Biotechnology News

May 31, 2012

BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq:SGEN) announced today that management will present at the following upcoming investor conferences. The presentations will be webcast live and available for replay from Seattle...

May 31, 2012

NEEDHAM, Mass.--(BUSINESS WIRE)--Celldex Therapeutics, Inc. (Nasdaq: CLDX) today announced that Anthony S. Marucci, President and Chief Executive Officer of Celldex Therapeutics, Inc., will present at the Jefferies 2012 Global Healthcare...

May 31, 2012

BOSTON--(BUSINESS WIRE)--OvaScience™, a fertility company focused on the discovery, development and commercialization of new treatments for infertility, announced today that Michelle Dipp, M.D., Ph.D., chief executive officer of OvaScience, will...

May 31, 2012

WOBURN, Mass.--(BUSINESS WIRE)--ArQule announces upcoming presentation at Jefferies 2012 Global Healthcare Conference.

May 31, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Catabasis Pharmaceuticals, a clinical stage biopharmaceutical company dedicated to the discovery and development of innovative, effective and safe medicines for the treatment of inflammatory and metabolic...

May 31, 2012

SAN ANTONIO--(BUSINESS WIRE)--GenSpera appoints new Board member.

May 31, 2012

REDWOOD CITY, Calif.--(BUSINESS WIRE)--A.P. Pharma, Inc. today announced that an abstract analyzing a subset of efficacy results from its Phase 3 trial of APF530 has been published in conjunction with the ASCO Annual Meeting.

May 31, 2012

RESTON, Va.--(BUSINESS WIRE)--Govplace, a leading Solution Provider for the public sector, announced today that it is on a winning team of the CIO-SP 3 Government-Wide Acquisition Contract (GWAC). The contract was awarded to Hygeia Solutions...

May 31, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Verastem will present at Jefferies 2012 Global Healthcare Conference on June 7, 2012, at 9am ET.

May 31, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--bluebird bio, a world leader in the development of innovative gene therapies for severe genetic disorders, today announced that John Maraganore, Ph.D., has joined the company’s board of directors. Dr. Maraganore...

May 31, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix and Lecia collaborate to automate and reduce assay time for RNA in situ hybridization (ISH) tissue analysis to speed drug discovery and translational research applications.

May 31, 2012

WORCESTER, Mass.--(BUSINESS WIRE)--RXi Pharmaceuticals Corporation (OTCBB: RXII.OB) today announced that it has received clearance for its investigational new drug application (IND) from the U.S. Food and Drug Administration (FDA) to initiate...

May 31, 2012

ZURICH-SCHLIEREN, Switzerland--(BUSINESS WIRE)--Molecular Partners AG, the leader in the discovery and development of DARPins®, a novel class of therapeutic proteins, today announced the appointment of Lisa Rojkjaer, MD as Chief Medical Officer,...

May 31, 2012

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum announces key ZEVALIN- and belinostat-related abstracts at ASCO annual meeting.

May 31, 2012

DUBLIN--(BUSINESS WIRE)--Alkermes plc (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live at the Jefferies 2012 Global Healthcare Conference on Tuesday, June 5, 2012, at 10:00 a.m. EDT (3:00 p.m. BST) in New York...

May 31, 2012

MANSFIELD, Mass.--(BUSINESS WIRE)--Covidien (NYSE: COV), a leading global provider of healthcare products, will present at the Goldman Sachs 33rd Global Healthcare Conference in Rancho Palos Verdes, CA, on Thursday, June 7, 2012. José E. Almeida...

May 31, 2012

EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NYSE Amex: AIS) today announced that Paul K. Wotton, Ph.D., President and Chief Executive Officer, will present at the 2012 Jefferies Global Healthcare Conference on Thursday June 7, 2012 at 3:...

May 31, 2012

SAN DIEGO--(BUSINESS WIRE)--Illumina (NASDAQ:ILMN) today introduced the Nextera XT DNA Sample Preparation Kit, the easiest way for researchers to prepare and sequence small genomes, PCR amplicons, and plasmids. When paired with Illumina’s MiSeq...

May 31, 2012

HAWTHORNE, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) will present research at the 4th Collaborative Meeting of the Consortium of Multiple Sclerosis Centers (CMSC) and Americas Committee for Treatment and Research in Multiple...

May 31, 2012

CHARLOTTESVILLE, Va.--(BUSINESS WIRE)--Tau Therapeutics has initiated a Phase Ib clinical trial with the NCI’s Adult Brain Tumor Consortium using the T-type calcium channel inhibitor mibefradil in patients with recurrent high-grade glioma.

May 31, 2012

NOKOMIS, Fla.--(BUSINESS WIRE)--RBCC Anticipates Favorable Test Results of New Brain Injury Treatment

May 31, 2012

MORRIS PLAINS, N.J.--(BUSINESS WIRE)--Temptime Corporation, the world leader in time temperature indicators, announced the opening of a business office in Beijing, China, marking a significant advancement in their global effort to improve...

May 31, 2012

TOKYO--(BUSINESS WIRE)--R-Tech Ueno (JASDAQ:4573) has announced that it has been notified by the International Court of Arbitration, International Chamber of Commerce (ICC), that the anticipated date of the arbitration decision has been extended...

May 31, 2012

SOLNA, Sweden--(BUSINESS WIRE)--Regulatory News: Aerocrine (STO:AEROB): With reference to Chapter 4 Section 9 in ”lagen (1991:980) om handel med finansiella instrument” it’s hereby announced that through the completion of a new share issue,...

May 31, 2012

SOPHIA ANTIPOLIS, France--(BUSINESS WIRE)--Regulatory News: MEDIAN Technologies (Paris:ALMDT), a leading medical imaging software developer and service provider for oncology clinical trials, announced today its participation in the 2012 ASCO...

May 31, 2012

BAGNEAUX, France--(BUSINESS WIRE)--Regulatory News: DBV Technologies (Paris:DBV) (Euronext: DBV – ISIN: FR0010417345), creator of Viaskin®, a new standard in the treatment of allergy, announced today the appointment of Pr. Hugh Sampson to its...

May 30, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI), a global leader focused on improving the health and safety of people and the environment, today announced that the Company will present at the Goldman Sachs Global Healthcare...

May 30, 2012

MINNEAPOLIS--(BUSINESS WIRE)--Minnesota Lt. Governor and Commissioners Visit Biobased Chemicals Industry Leaders.

May 30, 2012

TORONTO--(BUSINESS WIRE)--SQI Reports Second Quarter Results

May 30, 2012

TORONTO--(BUSINESS WIRE)--Medworxx announces highest quarter of revenues achieved since the company’s inception.

May 30, 2012

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE: BAX) announced today that it will present at the William Blair & Company 32nd Annual Growth Stock Conference on Thursday, June 14, 2012, at 8:40 a.m. CT. The live webcast of...

May 30, 2012

DUBLIN--(BUSINESS WIRE)--Alkermes plc (NASDAQ: ALKS) today announced topline results from a phase 2b dose-ranging clinical study of ALKS 37 in the treatment of opioid-induced constipation. The multicenter, randomized, double-blind, placebo-...

May 30, 2012

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals (NYSE: NAVB) to Present at the Jefferies 2012 Global Healthcare Conference on June 6: Chief Business Officer to Provide Business and Development Program Updates

May 30, 2012

SAN FRANCISCO--(BUSINESS WIRE)--Marathoners taking a natural immune health ingredient had 40% fewer days of respiratory infection symptoms, according to research presented today at the American College of Sports Medicine.

May 30, 2012

BOULDER, Colo.--(BUSINESS WIRE)--Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will speak at the Jefferies 2012 Global Healthcare Conference in New York City. The public is welcome to...

May 30, 2012

COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Cannabis Science, Inc. (OTCBB: CBIS) a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products, is excited to announce that it has created the “Cannabis Science Research...

May 30, 2012

SAN DIEGO--(BUSINESS WIRE)--Polynoma, Inc., an oncology-focused biotechnology company within Hong Kong-based CK Life Sciences Int’l., (Holdings) Inc., today announced the appointment of John Chiplin, Ph.D., to the newly established position of...

May 30, 2012

CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that Chariton County Ambulance District in Salisbury, Missouri, successfully revived two people from...

May 30, 2012

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) will host a live audio webcast at the Sanford C. Bernstein Twenty-Eighth Annual Strategic Decisions Conference in New York. Dr. Jeremy Levin, President and CEO, will...

May 30, 2012

WASHINGTON--(BUSINESS WIRE)--The Biotechnology Industry Organization is pleased to announce the Pipelines of Promise Buzz of BIO winner for the 2012 BIO International Convention is Deuteria Pharmaceuticals, Inc.

May 30, 2012

NEW YORK--(BUSINESS WIRE)--The International AIDS Vaccine Initiative (IAVI) is pleased to announce the appointment of Louis Schwartz as Chief Financial Officer.

May 30, 2012

KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus Pharmaceuticals has appointed Doug Ulman, President and CEO of LIVESTRONG, and national cancer survivorship advocate, to its Corporate Advisory Board.

May 30, 2012

FORT COLLINS, Colo.--(BUSINESS WIRE)--VetDC, Inc., today announced that it is presenting data on VDC-1101 at the 2012 American College of Veterinary Internal Medicine Forum. VDC-1101 is a novel anti-proliferative agent that preferentially targets...

May 30, 2012

MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences will present at the Jefferies Global Healthcare and William Blair & Company Growth Stock Conferences during June.

May 30, 2012

OTTAWA, Ontario--(BUSINESS WIRE)--BIOTECanada is pleased to announce Amgen Canada as the winner of the 2012 Gold Leaf Award in recognition of the company’s contributions to Canadian communities. The Contribution to Canadian Communities - Company...

May 30, 2012

SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) partner GlaxoSmithKline plc announced today that it has submitted regulatory applications in the United States and European Union related to eltrombopag (Promacta®/...

May 30, 2012

EXTON, Pa.--(BUSINESS WIRE)--75 percent of surveyed rheumatologists have tried Bristol-Myers Squibb’s Orencia SC after six months on the market, according to BioTrends

May 30, 2012

BELLEVUE, Wash.--(BUSINESS WIRE)--Kona Medical, Inc. today announced it has raised $30 million in Series C financing to advance its novel hypertension therapy.

May 30, 2012

MONROVIA, Calif.--(BUSINESS WIRE)--Prolacta Bioscience has made an additional donation to Make-A-Wish®, bringing their donation total to just over $18,000 in six months.